unknown
Stage
2018
Founded
5
Investors
About
TreeFrog Therapeutics develops a proprietary C‑Stem® 3D scalable manufacturing platform for induced pluripotent stem cell (iPSC) therapies to reduce production costs and support cell therapy clinical development and market access. The company partners with other cell therapy players to secure cell production and quality through its end-to-end manufacturing solution.
Explore TreeFrog Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.